Clinical trial
Multitarget Therapy for Idiopathic Membranous Nephropathy
NCT04424862 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multitarget Therapy for Idiopathic Membranous Nephropathy
- Lead sponsor
- Beijing Friendship Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 9, 2020
- Completion date
- February 3, 2022
- Enrollment
- 82 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
efficacy